PARIS (Reuters) - L'Oreal has taken stakes in clinics in China and North America in order to observe and understand the medical aesthetics market, L'Oreal CEO Nicolas Hieronimus said in an earnings call on Friday.

The company had announced in August the acquisition of a 10% stake in Swiss skin care firm Galderma.

Hieronimus added that L'Oreal would be entering the nutricosmetics market with a new product and said more would be coming.